ProMIS Neurosciences, Inc.
PMN
$7.55
$0.111.50%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 11.97% | 60.13% | |||
| Gross Profit | -11.97% | -60.13% | |||
| SG&A Expenses | 36.11% | -28.10% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.37% | 36.52% | |||
| Operating Income | -15.37% | -36.52% | |||
| Income Before Tax | -14.46% | -37.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -14.46% | -37.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -14.46% | -37.69% | |||
| EBIT | -15.37% | -36.52% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 18.31% | -37.71% | |||
| Normalized Basic EPS | 18.31% | -37.63% | |||
| EPS Diluted | 17.32% | -37.71% | |||
| Normalized Diluted EPS | 18.31% | -37.63% | |||
| Average Basic Shares Outstanding | 40.13% | 0.00% | |||
| Average Diluted Shares Outstanding | 40.13% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||